Related Experiment Video

Updated: Jun 13, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Distinct biological roles for the akt family in mammary tumor progression

Rachelle L Dillon1, William J Muller

  • 1Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Manitoba, Canada.

Cancer Research
|April 29, 2010
PubMed

Insights

The phosphatidylinositol 3

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The phosphatidylinositol 3' kinase/Akt pathway is crucial in cancer, impacting cell proliferation, survival, metabolism, and migration.
  • Akt1, Akt2, and Akt3 isoforms have distinct roles in breast cancer initiation and progression.
  • Akt1 accelerates mammary tumor induction, while Akt2 promotes metastasis without affecting tumor latency.

Purpose of the Study:

  • To explore the mechanisms underlying the distinct functional specificities of Akt1 and Akt2.
  • To understand how these highly related kinases contribute differently to cancer cell migration, invasion, and metastasis.

Main Methods:

  • Comparative analysis of Akt1 and Akt2 functions in breast cancer models.
  • Investigation of molecular mechanisms driving isoform-specific phenotypes.
  • Review of existing literature on Akt pathway dysregulation in cancer.

Main Results:

  • Akt1 activation accelerates mammary tumor development in transgenic mice.
  • Akt2 activation promotes tumor cell metastasis independently of tumor initiation.
  • Distinct phenotypic outcomes arise from Akt1 versus Akt2 activation.

Conclusions:

  • Akt1 and Akt2 exhibit unique roles in breast cancer progression, particularly in metastasis.
  • Further research is needed to elucidate the specific molecular mechanisms driving these functional differences.
  • Understanding these distinct roles could lead to targeted therapeutic strategies for breast cancer.

More Related Videos

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland06:29

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland

Published on: June 7, 2019

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...